| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Short Communications |

From the Division of Neurology,*
Department of Internal
Medicine, Saga Medical School, Saga; and the Department of
Bacteriology,
Nagasaki University School of
Medicine, Nagasaki, Japan
To investigate the physiological function of the cellular isoform of prion protein (PrPC), the gene expression profile was studied by analyzing a cDNA expression array containing 597 clones of various functional classes in two distinct skin fibroblast cell lines designated SFK and SFH, established from PrP-deficient (PrP-/-) mice and PrP+/+ mice, respectively. The cells were incubated in the culture medium with or without inclusion of basic fibroblast growth factor (bFGF). When SFK cells were compared with SFH cells in untreated conditions, the expression of 15 genes, including those essential for cell proliferation and adhesion, was reduced, whereas the expression of 27 genes, including those involved in the insulin-like growth factor-I (IGF-I) signaling pathway, was elevated. Northern blot analysis verified a significant down-regulation of the receptor tyrosine kinase substrate Eps8, cyclin D1, and CD44 mRNAs, and a substantial up-regulation of phosphatidylinositol 3-kinase p85, IGF-I, and serine protease inhibitor-2.2 mRNAs in SFK cells. The patterns of induction or reduction of gene expression after exposure to bFGF showed considerable overlap between both cell types. Furthermore, both Eps8 and CD44 mRNA levels were reduced greatly in the brain tissues of the cerebrum isolated from the PrP-/- mice. These results indicate that the disruption of the PrP gene resulted in an aberrant regulation of a battery of genes important for cell proliferation, differentiation, and survival, including those located in the Ras and Rac signaling pathways.
This article has been cited by other articles:
![]() |
R. Linden, V. R. Martins, M. A. M. Prado, M. Cammarota, I. Izquierdo, and R. R. Brentani Physiology of the Prion Protein Physiol Rev, April 1, 2008; 88(2): 673 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Liang, Y. Pan, D. Zhang, C. Guo, Y. Shi, J. Wang, Y. Chen, X. Wang, J. Liu, X. Guo, et al. Cellular prion protein promotes proliferation and G1/S transition of human gastric cancer cells SGC7901 and AGS FASEB J, July 1, 2007; 21(9): 2247 - 2256. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Pan, L. Zhao, J. Liang, J. Liu, Y. Shi, N. Liu, G. Zhang, H. Jin, J. Gao, H. Xie, et al. Cellular prion protein promotes invasion and metastasis of gastric cancer FASEB J, September 1, 2006; 20(11): 1886 - 1888. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Viguie, Y Chilliard, V Gayrard, N Picard-Hagen, P Monget, A Dutour, and P-L Toutain Alterations of somatotropic function in prion disease in sheep J. Endocrinol., November 1, 2004; 183(2): 427 - 435. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Burthem, B. Urban, A. Pain, and D. J. Roberts The normal cellular prion protein is strongly expressed by myeloid dendritic cells Blood, December 15, 2001; 98(13): 3733 - 3738. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-i. Satoh and Y. Kuroda Differing effects of IFN{beta} vs IFN{gamma} in MS: Gene expression in cultured astrocytes Neurology, August 28, 2001; 57(4): 681 - 685. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |